3D printing helps doctors rehearse complex brain procedures
Boston Children
Boston Children
Seven consensus statements developed by 23 international opinion leaders in the acute care of patients with severe traumatic brain injury (sTBI) provide a clear interpretation of clinical trial results that compared intracranial pressure (ICP)-based management to a treatment protocol guided by CT-imaging and examination without ICP monitoring. Results of the BEST TRIP trial led to on-going debate over the value of ICP monitoring in sTBI. These new consensus statement, which will help guide practicing physicians and researchers, are free.
In ‘A Consensus-Based Interpretation of the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure Trial,’ Randall Chesnut, MD, University of Washington, Seattle, and an international team of researchers present their consensus opinions on the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure (BEST TRIP). The seven consensus statements that emerged from their discussions help clarify the trial protocols, the different patient outcomes with and without ICP monitoring, the validity of the trial, and the main implications of the trial results.
‘This brief but eloquent consensus report helps revisit the overall implications and interpretations derived from the BEST TRIP trial,’ says John T. Povlishock, PhD, Editor-in-Chief of Journal of Neurotrauma and Professor, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond. ‘As noted by the authors, this consensus document reframes many of the controversial issues generated in this initial trial, calling for a more critical evaluation of the study and its overall interpretation. From my perspective as Editor-in-Chief, I believe the consensus positions detailed therein help place this trial in the appropriate intellectual framework, while highlighting the continued need for more rigorous evaluation of intracranial hypertension, its monitoring, and its implications for traumatically brain-injured patients.’ EurekAlert
You can whack it with a hammer, attack it with a drill, even stab it with a screwdriver. But try as you might, you won’t be able to tamper with a high-tech pill dispenser designed by mechanical engineering students at Johns Hopkins University’s Whiting School of Engineering.
Which is exactly the point.
The U.S. Centers for Disease Control and Prevention has estimated that drug overdoses kill more than 44,000 Americans annually, including more than 16,000 deaths from prescription drugs. Federal officials also say that at least one in 20 Americans ingests drugs prescribed for someone else. Concerned about these alarming statistics, experts at the Johns Hopkins Bloomberg School of Public Health’s Center for Injury Research and Policy challenged a team of Johns Hopkins senior mechanical engineers to design and build an anti-theft and tamper-resistant pill dispenser.
‘We needed this personal pill ‘safe’ to have tamper resistance, personal identification capabilities, and a locking mechanism that allows only a pharmacist to load the device with pills,’ said Kavi Bhalla, assistant professor at the university’s Bloomberg School of Public Health and one of the team’s mentors for the project.
Classmates Megan Carney, Joseph Hajj, Joseph Heaney, and Welles Sakmar
A new study co-authored by investigators at the University of Massachusetts Medical School found that there is no correlation between opioids administered in the emergency room setting and Press Ganey ED patient satisfaction scores, one of the most commonly used metrics for measuring patient satisfaction. Based on these findings, the study
Physicists from the University of Sydney have devised a way to use diamonds to identify cancerous tumours before they become life threatening.
Their reveal how a nano-scale, synthetic version of the precious gem can light up early-stage cancers in non-toxic, non-invasive Magnetic Resonance Imaging (MRI) scans.
Targeting cancers with tailored chemicals is not new but scientists struggle to detect where these chemicals go since, short of a biopsy, there are few ways to see if a treatment has been taken-up by a cancer.
Led by Professor David Reilly from the School of Physics, researchers from the University investigated how nanoscale diamonds could help identify cancers in their earliest stages.
‘We knew nano diamonds were of interest for delivering drugs during chemotherapy because they are largely non-toxic and non-reactive,’ says Professor Reilly.
‘We thought we could build on these non-toxic properties realizing that diamonds have magnetic characteristics enabling them to act as beacons in MRIs. We effectively turned a pharmaceutical problem into a physics problem.’
Professor Reilly’s team turned its attention to hyperpolarizing nano-diamonds, a process of aligning atoms inside a diamond so they create a signal detectable by an MRI scanner.
‘By attaching hyperpolarized diamonds to molecules targeting cancers the technique can allow tracking of the molecules’ movement in the body,’ says Ewa Rej, the paper’s lead author.
‘This is a great example of how quantum physics research tackles real-world problems, in this case opening the way for us to image and target cancers long before they become life-threatening,’ says Professor Reilly.
The next stage of the team’s work involves working with medical researchers to test the new technology on animals. Also on the horizon is research using scorpion venom to target brain tumours with MRI scanning.
University of Sydneyhttp://tinyurl.com/h8qj2ah
Researchers at The Ohio State University Wexner Medical Center have shown that patients who have chronic pain can reduce their emotional response to the pain through spinal cord stimulation.
A clinical trial by University of Colorado Cancer Center investigators and collaborators at Beaumont Health in Michigan and the University of Texas Medical Branch is evaluating a new method for pinpointing and sparing healthy lung tissue during lung cancer radiotherapy. The group is applying advanced image analysis techniques to 4D CT scans already performed as a standard step in targeting lung cancer radiotherapy, to map areas of lung function without additional testing.
Researchers at Case Western Reserve University have developed a magnetic resonance imaging (MRI) contrast agent that detects much smaller aggressive breast cancer tumours and micrometastases than current agents can identify.
Protective mastectomies that preserve the nipple and surrounding skin prevent breast cancer as effectively as more invasive surgeries for women with a genetic mutation called BRCA that raises their risk of developing breast cancer, a multi-institution study led by Mayo Clinic found. The research should reassure patients and surgeons that nipple-sparing mastectomies, which leave women with more natural-looking breasts than other mastectomies, are a safe way to reduce breast cancer risk in BRCA carriers, the authors say..
A new study from the University of Pennsylvania School of Nursing
April 2024
The medical devices information portal connecting healthcare professionals to global vendors
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy